Press release
Increasing Prevalence of Chronic Diseases Driving Pharmaceutical Excipients Market at 6.8% CAGR by 2031
Pharmaceutical Excipients Market
[https://www.skyquestt.com/report/pharmaceutical-excipients-market] size was valued at USD 10.12 billion in 2023 to USD 17.13 billion by 2031, growing at a CAGR of 6.8% in the forecast period (2024-2031).The pharmaceutical enterprise has step by step identified binders which will assist energetic pharmaceutical substances in achieving higher functionality and imparting a competitive benefit. Additionally, with the growth in the manufacturing of prescription drugs, the requirement for binders is expected to increase, propelling the market.
Request your free sample PDF of the report today: https://www.skyquestt.com/sample-request/pharmaceutical-excipients-market
Business Verticals Improved Competitive Landscape in the Pharmaceutical Excipients Market
The pharmaceutical excipients market presents a dynamic competitive environment driven by interactions between leading pharmaceutical excipient manufacturers, generic companies, organizations a contractor (CMOs), and emerging specialized players.
Major Excipients Manufacturers: Global leaders such as BASF, DuPont, Roquette and others dominate this segment, spending huge resources investing in R&D and expanding their product range. These large manufacturers deal with small pharmaceuticals and biologics, from binder supplements to disruption. Their competitive edge lies in their ability to develop new multifunctional excipients that improve drug efficacy, bioavailability and meet stringent regulatory standards. These companies are often with pharmaceuticals teams to work together to develop customized solutions, long-term contracts and market dominance.
Generic Companies: Manufacturers of generic drugs, such as Teva Pharmaceuticals and Mylan, rely on complementary solutions that cost less and fly more effectively to remain competitive. Adjuvants are increasingly important to ensure that generic drug products match the quality and activity of the branded drug. These companies tend to prioritize partnerships with smaller manufacturers that can offer high-quality products at competitive prices.
For a tailored report, contact us to request a free customization: https://www.skyquestt.com/speak-with-analyst/pharmaceutical-excipients-market
Competitive Landscape an Overview of the Pharmaceutical Excipients Market
The competitive environment in the pharmaceutical excipients market is characterized by intense competition among established players, technological advancements, and increasing emphasis on quality and regulatory compliance in the market growth is driven by innovation, collaboration and growing demand for pharmaceutical excipients that meet the evolving needs of pharmaceutical products.
Technological Innovation and R&D: The ability to develop new products to help deliver functional benefits such as increased drug solubility, improved bioavailability, and delivery time. Companies offering high-performance innovative adjuvants are well positioned to gain market share, especially as the pharmaceutical excipients industry moves toward more complex drugs.
Strategic Cooperation and Partnership
October 2023: Clariant, a leading pharmaceutical company focused on sustainability, launched its portfolio of high-performance formulation solutions to support safe and effective pharmaceuticals manufacturing. In addition, Clariant Health Care addresses active pharmaceutical (API) delivery & bioavailability challenges and expanded its range of business auxiliaries.
September 2023: Roquette, a company that focuses on plant-based products and provides pharmaceutical and nutritional supplements, offers three new complementary products to its solution portfolio of active liquid formulations cooling.
This report covers following segments:
A. Product
Organic Chemicals
Inorganic Chemicals
Other Chemicals
B. Functionality
Fillers & Diluents
Suspending & Viscosity Agents
Coating Agents
Binders
Flavoring Agents & Sweeteners
Disintegrants
Colorants
Lubricants & Glidants
Preservatives
Emulsifying Agents
Other Functionalities
C. Formulation
Oral Formulations
Topical Formulations
Parenteral Formulations
Other Formulations
D. Functionality Application
Stabilizers
Taste Masking
Modified Release
Solubility & Bioavailability Enhancement
Other Functionality Applications
This report covers following key players:
BASF SE
Ashland Inc.
Evonik Industries AG
Kerry Group PLC
Roquette Freres
Merck KGaA
Associated British Foods PLC
ADM
Wacker Chemie AG
Air Liquide
Dow
Lubrizol Corporation
Colorcon
DFE Pharma
Innophos
J. Rettenmaier & Sohne GmbH
Meggle GmbH & Co. KG
Fuji Chemical Industries Co., Ltd.
Corel Pharma Chem
Biogrund GmbH
Nitika Pharmaceutical Specialties Pvt. Ltd.
R.T. Vanderbilt Holding Company, Inc.
Beneo
Purchase now to gain valuable insights and stay informed: https://www.skyquestt.com/buy-now/pharmaceutical-excipients-market
Catalyzing the Future of Pharmaceutical Excipients Market
The pharmaceutical excipients market is about to enjoy robust growth due to the demand for novel drug formulations and advanced delivery systems increases. Excipients, which play an important position in drug stability, bioavailability, and patient compliance, are gaining extra attention from pharmaceutical producers. With innovations in biologics, sustained-release formulations, and personalized medicine, excipient manufacturers are poised to expand their market share by developing new, multifunctional excipients. As R&D in drug development continues to advance, the pharmaceutical excipients market will remain an essential component in the future of healthcare.
To read the full report, please visit: https://www.skyquestt.com/report/pharmaceutical-excipients-market
Media Contact
Company Name: Skyquest Technology
Contact Person: Mr. Jagraj Singh
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=increasing-prevalence-of-chronic-diseases-driving-pharmaceutical-excipients-market-at-68-cagr-by-2031]
Phone: +1 351-333-4748
Address:1 Apache Way, Westford,
Country: United States
Website: https://www.skyquestt.com/report/pharmaceutical-excipients-market
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Increasing Prevalence of Chronic Diseases Driving Pharmaceutical Excipients Market at 6.8% CAGR by 2031 here
News-ID: 3699225 • Views: …
More Releases from ABNewswire
Custom Packaging Boxes With Logo: Branding Guide
Image: https://www.abnewswire.com/upload/2026/02/a85b0085c76a144c61cb76a8aed92b66.jpg
In today's market, your product should stand out. Great products are crucial. But presentation could make or damage first impressions. This is where custom packaging containers play an important position. Packaging that carries your brand is no longer an afterthought. It is a strategic tool for brand success.
Customers decide great inside seconds. Packaging is frequently the primary tangible interplay they've with your emblem. It shapes their expectations and feelings.…
Nutritionsly Recognizes CoreAge Rx as the World's Best GLP-1 Provider, Highlight …
Image: https://www.abnewswire.com/upload/2026/02/49a060b2c5ce8e5e3c8c09910a5507f2.jpg
Nutritionsly has named CoreAge Rx as the Best GLP-1 provider in the world [https://www.nutritionsly.com/complete-review-of-coreage-rx-and-what-makes-it-the-best-glp-1-brand-in-2026/], recognizing the company's transparent pricing structure, licensed healthcare oversight, and comprehensive telemedicine-based weight management program. The recognition highlights CoreAge Rx's continued expansion as a structured and accessible provider of GLP-1 medications delivered through a streamlined virtual care model.
CoreAge Rx [https://www.coreagerx.com/] provides access to GLP-1 medications including semaglutide and tirzepatide through a fully integrated telemedicine platform.…
The LegalTech Platform Lawyers Actually Open Every Morning - How Phenomenon Stud …
(By Iryna Huk - Project Manager Lead, Phenomenon Studio February 18, 2026 LegalTech Compliance SaaS Web App Design)
Key Takeaways
LegalTech platforms fail adoption not because lawyers distrust technology - but because the products look and behave like they were designed for someone else. ClauseGuard was built with a user research foundation that put practicing attorneys in every design decision from day one.
Choosing web and design services [https://phenomenonstudio.com/web-design-services] that understand institutional trust…
Link Collection: The Smart Way to Organize, Share, and Discover the Best Online …
In today's fast-paced digital world, finding, saving, and managing useful links can quickly become overwhelming. Whether you are a student, entrepreneur, content creator, or casual internet user, keeping track of valuable websites is essential. This is where https://linkparty.clickn.co.kr/ comes in.
A link collection is a curated collection of useful, trending, and reliable links gathered in one convenient place. Platforms like http://linkparty.clickn.co.kr make it easier than ever to organize online resources, discover…
More Releases for Pharma
Schizophrenia Market: Expanding Revenue Landscape to 2034 - DelveInsight | Teva …
The Key Schizophrenia Companies in the market inlclude - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Reviva Pharmaceuticals, and others.
DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2034" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed insights into the disease, including historical and projected epidemiology, helping stakeholders understand the…
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
